Pharmaceutical Gallium Compositions and Methods
AssigneeGenta Incorporated
InventorsRaymond P. Warrell, JR., Bob D. Brown
Life of this patent
Estimating the term…
Abstract
The present invention provides novel pharmaceutical gallium compositions, as well as methods for their preparation and methods for treating conditions and diseases such as cancer, hypercalcemia, osteoporosis, osteopenia, Paget's disease, and infections.
Claims20
A method of treating a patient having a bacterial infection comprising systemically administering to said patient a compound in an amount sufficient to treat said infection, wherein the compound has the general formula IV:
- [Cat]xGaLy[An]z.nH2O IV
- wherein [Cat] is a pharmaceutically acceptable cation, L is a pharmaceutically acceptable polycarboxylic acid, [An] is a pharmaceutically acceptable anion, x is 0-2, y is 1-6, z is 0-2, and n is 0-2 or n is 0-6.
A method for achieving preferentially higher concentrations of gallium in the lung and sputum of a patient as compared to concentration of gallium in plasma comprising systemically administering to the patient a compound having the general formula IV:
- [Cat]xGaLy[An]z.nH2O IV
- wherein [Cat] is a pharmaceutically acceptable cation, L is a pharmaceutically acceptable polycarboxylic acid, [An] is a pharmaceutically acceptable anion, x is 0-2, y is 1-6, z is 0-2, and n is 0-2 or n is 0-6.
Dependencies are inferred from the claim text.